Ica Group Wealth Management, LLC Dexcom Inc Transaction History

Ica Group Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$114.22 - $140.1 $13,706 - $16,812	120 Added 17.6%	802 $111,000
Q4 2023 Mar 07, 2024	BUY	$75.49 - $124.16 $51,484 - $84,677	682 New	682 $84,000
Q2 2023 Aug 11, 2023	SELL	$112.47 - $130.98 $7,647 - $8,906	-68 Reduced 8.4%	742 $95,000
Q1 2023 May 12, 2023	SELL	$104.0 - $122.92 $6,240 - $7,375	-60 Reduced 6.9%	810 $94,000
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $73,932 - $106,722	870 New	870 $98,000

1,016

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Ica Group Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Ica Group Wealth Management, LLC with notifications on news.